EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 3.0

Urachal carcinoma with liver, lung, and brain metastases: benefit of a new combination chemotherapy (bevacizumab, 5-fluorouracil, irinotecan) – case report

Filip Geurs, Pieter Demetter, Filip Geurs, R. Deloecker

Clinical Oncology in Adolescents and Young Adults · 2011

DOI: 10.2147/coaya.s18841 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Oncology in Adolescents and Young Adults, 2011. Verfasst von Filip Geurs und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Geurs, F., Demetter, P., Geurs, F., & Deloecker, R. (2011). Urachal carcinoma with liver, lung, and brain metastases: benefit of a new combination chemotherapy (bevacizumab, 5-fluorouracil, irinotecan) – case report. Clinical Oncology in Adolescents and Young Adults. https://doi.org/10.2147/coaya.s18841

Vancouver

Geurs F, Demetter P, Geurs F, Deloecker R. Urachal carcinoma with liver, lung, and brain metastases: benefit of a new combination chemotherapy (bevacizumab, 5-fluorouracil, irinotecan) – case report. Clinical Oncology in Adolescents and Young Adults. 2011. doi:10.2147/coaya.s18841

BibTeX
@article{Geurs2011,
  author = {Geurs, Filip and Demetter, Pieter and Geurs, Filip and Deloecker, R.},
  title = {Urachal carcinoma with liver, lung, and brain metastases: benefit of a new combination chemotherapy (bevacizumab, 5-fluorouracil, irinotecan) – case report},
  journal = {Clinical Oncology in Adolescents and Young Adults},
  year = {2011},
  doi = {10.2147/coaya.s18841}
}
Kostenlos starten →